- Patent Title: Cycloalkyl substituted pyrimidinediamine compounds and their uses
-
Application No.: US13757262Application Date: 2013-02-01
-
Publication No.: US09725419B2Publication Date: 2017-08-08
- Inventor: Hui Li , Ankush Argade , Rajinder Singh , Sambaiah Thota , David Carroll , Kin Tso , Vanessa Taylor , John McLaughlin , Vadim Markovtsov
- Applicant: Rigel Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: McDonnell Boehnen Hulbert & Berghoff LLP
- Agent Travis Young
- Main IPC: C07D403/12
- IPC: C07D403/12 ; A61K31/505 ; C07D239/48 ; A61K31/506 ; C07D205/12 ; C07D239/42 ; C07D401/12 ; C07D405/12 ; C07D413/12 ; C07D487/08 ; C07D295/155 ; C07D417/12 ; C07D471/08
Abstract:
The present disclosure provides 2,4-pyrimidinediamine compounds having antiproliferative activity, compositions comprising the compounds and methods of using the compounds to inhibit cellular proliferation and to treat proliferate diseases such as tumorigenic cancers.
Public/Granted literature
- US20130210814A1 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses Public/Granted day:2013-08-15
Information query
